Dr. Felix Feng Selected as the New NRG Oncology Genitourinary Cancer Committee Chair

NRG Oncology has appointed Felix Feng, MD of the University of California at San Francisco as Chair of its Genitourinary Cancer Committee. He will follow Howard M. Sandler, MD, MS, who dedicated twenty-one years of leadership and direction for the committee.

Dr. Feng, a nationally and internationally recognized expert in the care of patients with genitourinary malignancies, has helped to initiate several clinical trials which have been among the first to utilize genomic biomarkers to help personalize therapy for prostate cancer patients.

Click here to view the full press release

More NRG Oncology news can be found at

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.
This message was sent from to
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103

Update Profile/Email Address | Forward Email | Report Abuse